Adaptive Clinical's Tope Keyes on clinical trials in the COVID-19 era (podcast)

[audio mp3="https://healthbusinessgroup.com/wp-content/uploads/2020/06/Tope-Keyes-Adaptive-Clinical.mp3"][/audio]TK head shot 1Thanks to COVID-19, the era of decentralized trials is now upon us. In this podcast interview, Adaptive Clinical Systems' Temitope Keyes and I discuss how trials are changing and what clinical data infrastructure is needed to make them flow smoothly.Questions include:

  • Changes are underway in clinical trials right now as a result of COVID-19
  • The imperative for “frictionless clinical data.”
  • Ensure optimal performance in the new environment
  • New data sources and endpoints that will be employed
  • Technological innovations that we can expect

Tope will be a panelist on a webinar I'm moderating on July 8: Moving Clinical Trials Forward with Digital Innovation in the COVID Era. We'll be joined by Mark Mann of The Oxenham Group and Bob O'Hara of ResultWorks. Please register --the webinar is complimentary.


By healthcare business consultant David E. Williams, president of Health Business Group.

Previous
Previous

Massachusetts school reopening plan gets an A from me

Next
Next

Elective procedures and the second wave of COVID-19